Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study

The objective of the study was to compare the efficacy and safety of frovatriptan and almotriptan in women with menstrually related migraine (IHS Classification of Headache disorders) enrolled in a multicenter, randomized, double-blind, cross-over study. Patients received frovatriptan 2.5 mg or almo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartolini, Marco, Giamberardino, Maria Adelaide, Lisotto, Carlo, Martelletti, Paolo, Moscato, Davide, Panascia, Biagio, Savi, Lidia, Pini, Luigi Alberto, Sances, Grazia, Santoro, Patrizia, Zanchin, Giorgio, Omboni, Stefano, Ferrari, Michel D., Fierro, Brigida, Brighina, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2012
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381066/
https://www.ncbi.nlm.nih.gov/pubmed/22592864
http://dx.doi.org/10.1007/s10194-012-0455-4

Ejemplares similares

Ejemplares similares